CRANBURY, N.J.–()–Cannabis Science and Technology® is happy to announce a brand new sister publication, Cannabis Patient Care, devoted to medical hashish protection.

Each difficulty of Cannabis Patient Care will deal with a single illness or ailment for which medical hashish has confirmed efficient for treating and present analysis, affected person tales and insights from medical professionals to additional educate the medical hashish neighborhood.

Cannabis Science and Technology® has established itself as a thought leader in the cannabis industry by delivering accurate and relevant scientific information to the community,” stated Mike Hennessy Jr., president and CEO of MJH Life Sciences, the father or mother firm of Cannabis Science and Technology®. “As we strive to grow that brand, we continue to look for opportunities to educate the cannabis community in new ways, and Cannabis Patient Care will be the next chapter in our success by educating health care providers and improving patients’ lives.”

The first version of Cannabis Patient Care focuses on veterans utilizing medical hashish to deal with post-traumatic stress dysfunction (PTSD). It was created in partnership with Dr. Marion McNabb, president of Cannabis Center of Excellence, INC.; Ann M. Brum, founder and CEO of Joint Venture & Co.; and Stephen Mandile, veteran, hashish affected person and advocate — who collectively carried out the 2019 Veterans Health and Medical Cannabis Study to lift consciousness and assist change coverage surrounding veteran entry to medical hashish in Massachusetts.

In this primary difficulty of Cannabis Patient Care, McNabb highlights a few of their information and insights, Brum particulars her story as an advocate for veteran entry and Mandile shares his private story as a veteran affected person. The difficulty additionally options an interview with Dr. Staci Gruber, the director of Marijuana Investigations for Neuroscientific Discovery (MIND) at McLean Hospital who’s been learning the impression of hashish on the mind for greater than 20 years, in addition to conversations with a hospice nurse who works with veterans, a Veterans Affairs caregiver and a veteran advocate.

“This research study examined the use of medical cannabis among U.S. military veterans and found cannabis is most commonly used to address PTSD, chronic pain, anxiety, and depression,” stated McNabb. “In our sample, 76% of veterans report actively using cannabis to replace or reduce the use of over the counter or prescription medications. Given the self-reported benefits of using medical cannabis among veterans, further inquiry into the benefits and risks of use for specific health conditions and symptoms should be prioritized.”

To complement the publication launch, Cannabis Science and Technology® and Cannabis Patient Care will host a free Veterans Day webinar on Nov. 11 at 11 a.m. EST titled, “From Post-Traumatic Stress to Post-Traumatic Growth: How Medical Cannabis Is Helping Veterans with PTSD.” For extra data and to register for the webinar, click on here.

Cannabis Patient Care will donate a portion of its first-edition proceeds to TAPS.org, a nationwide nonprofit 501(c)three veterans service group that gives consolation, care and sources to all these grieving the demise of a army cherished one. To donate, go to https://taps.revv.co/cst.

About Cannabis Science and Technology®

Cannabis Science and Technology® is a multimedia platform that focuses on educating the authorized hashish trade concerning the science and expertise of analytical testing, high quality management, extraction and cultivation. The journal is accompanied by a web based part that gives related data and tutorials for all members of the hashish trade. Cannabis Science and Technology® is a model of MJH Life Sciences, the most important privately held, unbiased, full-service medical media firm in North America devoted to delivering trusted well being care information throughout a number of channels.

About Cannabis Center of Excellence

The Virtual Cannabis Center of Excellence, INC. (CCOE, INC.) is a registered 501c3 non-profit group primarily based in Massachusetts that conducts citizen-science targeted inhabitants research and packages within the areas of neighborhood engagement, medical hashish, adult-use hashish, and social justice within the hashish trade. The CCOE serves as a digital useful resource and community of hashish trade professionals, lecturers, coverage makers, healthcare suppliers, customers, and sufferers who purpose to interrupt the stigma and advance social justice within the hashish trade.

About Joint Venture & Co.

Joint Venture & Co. is a New England progress company serving to hashish and wellness manufacturers deliberately develop their viewers and exceed the expectations of rising demand.

Source link